Study: Transparency Lacking in Biomedical Literature
By Anna Azvolinsky,
The Scientist
| 01. 04. 2016
Untitled Document
Despite a push for transparency in science, full data disclosure may be close to non-existent among published studies. Of 441 randomly selected biomedical research papers analyzed in a new study, none provided access to all the authors’ data. And only one of these papers shared a complete protocol. The results of this analysis, which could shed light on science’s reproducibility problem, were published today (January 4) in PLOS Biology.
“What was most surprising to me was the complete lack of data-sharing and protocol availability,” said study coauthor John Ioannidis, a professor of medicine and health research and policy at the Stanford University School of Medicine. “That was worse than I would have predicted.”
“This study confirms what most of us already know—that the current clinical research enterprise is set up in a way that researchers consider data their own assets,” said cardiologist Harlan Krumholz, leader of the Yale University Open Data Access Project, who was not involved in the work. “There is little investment, effort, or tools to support data-sharing broadly,” he said. “The advantage...
Related Articles
By Priyanka Runwal, Chemical and Engineering News | 08.05.2024
Saritee Sanodiya, 26, has spent countless days wondering if she’ll ever live a “normal” life. Growing up, Sanodiya often missed school, frequenting the hospital for sudden, life-threatening drops in her hemoglobin levels and excruciating pain in her joints. High fever...
By Gemma Conroy, Nature | 06.27.2024
Image by Robina Weermeijer from Unsplash
A molecular-editing tool that’s small enough to be delivered to the brain shuts down the production of proteins that cause prion diseases, a rare but deadly group of neurodegenerative disorders.
The system — known...
By Julia Black and Margaux MacColl, The Information [cites CGS' Katie Hasson] | 07.19.2024
When venture capitalist Jack Abraham first began dating his wife, Gabriella Massamillo, he insisted on one condition: that when they were ready to have children, she’d be willing to conceive using in vitro fertilization. Abraham had lost both his mother...
By Kevin Davies, Genetic Engineering & Biotechnology News | 06.27.2024
Physician-scientist Matthew Porteus, MD, PhD, has been a mainstay in the genome editing field for more than two decades. He trained at Stanford University Medical School before completing his residency and hematology/oncology fellowship at Boston Children’s Hospital/Dana Farber Cancer Institute...